(Q30369367)

21 June 2017

title

Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidate. (English)

1 reference

21 June 2017

1 reference

Shigella dysenteriae

1 reference

Robin McKenzie

1

1 reference

21 June 2017

Malabi M Venkatesan

2

1 reference

21 June 2017

Marcia K Wolf

3

1 reference

21 June 2017

Dilara Islam

4

1 reference

21 June 2017

Shannon Grahek

5

1 reference

21 June 2017

Andrea M Jones

6

1 reference

21 June 2017

Arlene Bloom

7

1 reference

21 June 2017

David N Taylor

8

1 reference

21 June 2017

Thomas L Hale

9

1 reference

21 June 2017

A Louis Bourgeois

10

1 reference

21 June 2017

language of work or name

English

0 references

publication date

16 April 2008

1 reference

21 June 2017

1 reference

21 June 2017

volume

26

1 reference

21 June 2017

issue

26

1 reference

21 June 2017

page(s)

3291-3296

1 reference

Shiga toxins and apoptosis

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

Epidemic Shiga-bacillus dysentery in Central America. Derivation of the epidemic and its progression in Guatemala, 1968-69.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

Epidemic shiga-bacillus dysentery in Central America. Evolution of the outbreak in El Salvador, 1969-70.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

Shigella dysenteriae serotype 1 in west Africa: intervention strategy for an outbreak in Sierra Leone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

Shigella dysenteriae type 1 infections in US travellers to Mexico, 1988.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

Epidemic Shigella dysenteriae type 1 in Burundi: panresistance and implications for prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

Shigella dysenteriae type 1 with reduced susceptibility to fluoroquinolones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

Genetic analysis of Escherichia coli K1 gastrointestinal colonization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

Molecular basis of reduced potency of underacylated endotoxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox- mutant of Shigella dysenteriae 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

inferred from DOI database lookup

7 January 2021

based on heuristic

Epidemiology of shigellosis among children exposed to cases of Shigella dysentery: a multivariate assessment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

inferred from DOI database lookup

7 January 2021

based on heuristic

Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.079

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2008.03.079

1 reference

21 June 2017

1 reference